Filtered By:
Condition: Heart Failure
Drug: Furosemide

This page shows you your search results in order of date.

Order by Relevance | Date

Total 17 results found since Jan 2013.

A Rapidly Accumulating Effusion in an Immunocompetent Woman
Chest. 2022 Jun;161(6):e377-e382. doi: 10.1016/j.chest.2021.12.665.ABSTRACTAn 87-year-old woman with a medical history of stroke, paroxysmal atrial fibrillation, type 2 diabetes mellitus, diastolic heart failure, and chronic bilateral lymphedema presents with 1 week of shortness of breath. The patient had a 20-pack-year smoking history and at baseline was able to ambulate freely without assistance. Her symptoms of dyspnea were mostly exertional and progressively worsening for 1 week before admission, despite compliance with her home furosemide. On admission, her temperature was 36.3 °C, BP was 101/59 mm Hg, heart rate was...
Source: Chest - June 9, 2022 Category: Respiratory Medicine Authors: Zein Kattih Akhilesh Mahajan Morana Vojnic Jordan Steinberg Alyssa Yurovitsky Jin Ah Kim Amory Novoselac Source Type: research

Pre ‐hospital management protocols and perceived difficulty in diagnosing acute heart failure
ConclusionsThe prevalence of AHF protocols is rather high but the contents seem to vary. Difficulty of diagnosing suspected AHF seems to be moderate compared with other pre ‐hospital conditions.
Source: ESC Heart Failure - November 7, 2019 Category: Cardiology Authors: Pia Harjola, Òscar Miró, Francisco J. Martín‐Sánchez, Xavier Escalada, Yonathan Freund, Andrea Penaloza, Michael Christ, David C. Cone, Said Laribi, Markku Kuisma, Tuukka Tarvasmäki, Veli‐Pekka Harjola, on behalf of the EMS‐AHF Study Tags: Original Research Article Source Type: research

Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR
In conclusion, baseline urine osmolality and change in free-water clearance with additive introduction of TLV and a changing ratio of BUN/Cr with increasing doses of FUR were identified as key clinical parameters related to diuretic response .Trial registration UMIN000009201.
Source: Heart and Vessels - February 7, 2019 Category: Cardiology Source Type: research

A clinical decision instrument to predict 30-day death and cardiovascular hospitalizations after an emergency department visit for atrial fibrillation: The Atrial Fibrillation in the Emergency Room, Part 2 (AFTER2) study
ConclusionsUsing a population-based sample, we derived and validated a tool that predicts the risk of early death and rehospitalization for a cardiovascular reason in emergency department AF patients. The tool can offer information to managing physicians about the risk of death and rehospitalization for AF patients seen in the in emergency department, as well as identify patient groups for future targeted interventions aimed at preventing these outcomes.Graphical AbstractThe Atrial Fibrillation in the Emergency Room, Part 2 (AFTER2) Study.
Source: American Heart Journal - July 24, 2018 Category: Cardiology Source Type: research

A clinical decision instrument to predict 30-day death & cardiovascular hospitalizations following an emergency department visit for atrial fibrillation: The atrial fibrillation in the emergency room, part 2 (AFTER2) study
ConclusionsUsing a population-based sample, we derived and validated a tool that predicts the risk of early death and re-hospitalization for a cardiovascular reason in emergency department AF patients. The tool can offer information to managing physicians about the risk of death and re-hospitalization AF patients seen in the in emergency department, as well as identify patient groups for future targeted interventions aimed at preventing these outcomes.Graphical AbstractThe Atrial Fibrillation in the Emergency Room, part 2 (AFTER2) Study
Source: American Heart Journal - July 10, 2018 Category: Cardiology Source Type: research

A clinical decision instrument to predict 30-day death & amp; cardiovascular hospitalizations following an emergency department visit for atrial fibrillation: The atrial fibrillation in the emergency room, part 2 (AFTER2) study
Conclusions Using a population-based sample, we derived and validated a tool that predicts the risk of early death and re-hospitalization for a cardiovascular reason in emergency department AF patients. The tool can offer information to managing physicians about the risk of death and re-hospitalization AF patients seen in the in emergency department, as well as identify patient groups for future targeted interventions aimed at preventing these outcomes. Graphical abstract
Source: American Heart Journal - June 13, 2018 Category: Cardiology Source Type: research

Outpatient Carpertide Infusion Therapy for a Patient With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Syndrome (MELAS)
A case was a 46 year-old woman. She had short stature, juvenile diabetes, hearing loss, LV hypertrophy and diagnosed as MELAS at age of 39 year-old. Echocardiography showed LVDd of 51  mm; LVDs of 39 mm; IVST of 14 mm; LVPWT of 14 mm; EF of 31%. Despites oral administration of furosemide 40 mg, tolvaptan 3.75 mg, eplerenone 25 mg, perindopril 2 mg, carvedilol 3.75 mg, pimobendan 2.5 mg, she repeated hospitalization for heart failure 5–6 times a year. Since c arperitide was very useful as inpatient treatment, we tried intermittent carperitide infusion therapy (starting with 0.033γ and increasing to 0....
Source: Journal of Cardiac Failure - September 20, 2017 Category: Cardiology Authors: Yuya Terao, Shota Yamana, Hajime Nakaoka, Yasuhiro Kaetsu, Hiroaki Nakamura, Katsunori Okajima, Makoto Kadotani, Hiroki Shimizu, Yoshio Onishi Source Type: research

Healthcare Team Attitudes Influencing the Use of Intravenous Furosemide in a Long Term Care Center for the Treatment of Acute Decompensated Heart Failure
For residents living in long term care (LTC), cardiovascular disease represents one of the broadest challenges. Included within this diagnostic category are a number of diseases such as hypertension, myocardial infarction, and ischemic stroke, with heart failure being one of the common complications. Among comorbidities seen in the elderly, acute decompensated heart failure (ADHF) exacerbations occur often and contribute to approximately 27-45% of the re-hospitalizations observed within thirty days post discharge into the LTC setting.
Source: Journal of the American Medical Directors Association - February 23, 2017 Category: Health Management Authors: Andrea Leschak, Tiffany Chhay, Andrea Leschak, F. Bahar Matusik, Jacinda Small Tags: Quality Improvement Source Type: research

Abstract 166: Developing the Veterans Affairs Cardiac Risk Score Session Title: Poster Session I
Conclusion: We demonstrated that an EHR in a specific population could risk-stratify patients as well those from as organized cohort studies and greatly improve calibration. Further, our finding that the ASCVD score greatly underpredicted in our population, while previous work have reported the ASCVD over-predictind in other cohorts, suggests that rather than arguing about which risk tool is best, our patients may be better served by us focusing on calibrating CV risk tools for our specific patient population using their EHR data.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Sussman, J. B., Wiitala, W., Hofer, T., Zawitowski, M., Vijan, S., Hayward, R. Tags: Session Title: Poster Session I Source Type: research

Diuretics: A Review and Update
In conclusion, diuretics are a diverse class of drugs that remain extremely important in the management of hypertension and hypervolemic states.
Source: Journal of Cardiovascular Pharmacology and Therapeutics - December 17, 2013 Category: Cardiology Authors: Roush, G. C., Kaur, R., Ernst, M. E. Tags: Cardiovascular Pharmacology Core Reviews Source Type: research

Short‐Term Hemodynamic and Neuroendocrine Effects of Pimobendan and Benazapril in Dogs with Myxomatous Mitral Valve Disease and Congestive Heart Failure
Conclusions and Clinical ImportancePimobendan improves short‐term cardiac function more than benazepril in dogs with CHF caused by MMVD. Pimobendan treatment enables the heart to work at smaller end‐systolic and diastolic dimensions while maintaining adequate forward stroke volume. Some of the treatment responses found in neuroendocrine profile might have therapeutic relevance.
Source: Journal of Veterinary Internal Medicine - September 1, 2013 Category: Veterinary Research Authors: J. Häggström, P.F. Lord, K. Höglund, I. Ljungvall, O. Jöns, C. Kvart, K. Hansson Tags: Original Article Source Type: research

The Assassin: Chagas Cardiomyopathy
A 35-year-old Salvadoran woman had been hospitalized for heart failure multiple times over a 5-year period, yet the etiology of her disease remained elusive. She also had a history of stroke. Again, she presented to the emergency department with shortness of breath, chest pain, and fatigue. Although these symptoms were chronic, they had been increasing for 3 weeks prior to admission. The patient denied fevers, chills, cough, or gastrointestinal complaints. She had no history of smoking, alcohol consumption, or illicit drug use. Her medications included carvedilol, furosemide, and warfarin.
Source: The American Journal of Medicine - July 19, 2013 Category: Journals (General) Authors: Uppinder K. Mattu, Gagan D. Singh, Jeffrey A. Southard, Ezra A. Amsterdam Tags: Diagnostic dilemma Source Type: research